TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8688215

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with cisplatin (100 mg/m2, D1) and fluorouracil (1 g/m2, D2‐4) followed by regional treatment
Number of subjects: 121

Group type: COMPARATOR
Intervention: Regional treatment alone
Number of subjects: 121
Study: 2019663

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Quinidine
Number of subjects: 114
Study: 7094361

Group type: EXPERIMENTAL
Intervention: Naloxone infusion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 6
Study: 31095004

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy initiation
Number of subjects: 181
Study: 29076171

Group type: EXPERIMENTAL
Intervention: Yoga intervention (2 sessions weekly for 12 weeks)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet (3 sessions of nutritional counselling over 12 weeks)
Number of subjects: 59
Study: 26979982

Group type: EXPERIMENTAL
Intervention: Computer-assisted motivational social network intervention (four biweekly sessions using motivational interviewing)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study: 25017530

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 mcg once daily
Number of subjects: 373

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 373
Study: 22189199

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 5411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5411
Study: 19958238

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17400672

Group type: EXPERIMENTAL
Intervention: Atrial septostomy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Supplemental O2 therapy
Number of subjects: 11
Study: 15724143

Group type: EXPERIMENTAL
Intervention: High-dose levothyroxine (L-T(4)), mean dose 320 microg/day, adjunctive treatment for 7 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (age-matched healthy women without L-T(4) treatment)
Number of subjects: 10
Study: 12040338

Group type: EXPERIMENTAL
Intervention: 6-hour patency group
Number of subjects: 80

Group type: COMPARATOR
Intervention: 6-hour occlusion group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: BNP level at 24 hours
Number of subjects: 80
Study: 9471040

Group type: EXPERIMENTAL
Intervention: Casodex 50 mg daily
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Casodex 100 mg daily
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Casodex 200 mg daily
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Casodex (all doses)
Number of subjects: 390
Study: 7613148

Group type: EXPERIMENTAL
Intervention: Oral provocation tests (OPTs) with the suspected drug
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Concomitant ARs to other mild analgesics during OPTs
Number of subjects: 128

Group type: COMPARATOR
Intervention: Oral provocation tests (OPTs)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Standard battery of different analgesics in OPTs
Number of subjects: 128

Group type: COMPARATOR
Intervention: Single preparation recommendation (e.g., acetaminophen) without OPT
Number of subjects: 128
Study: 2375235

Group type: EXPERIMENTAL
Intervention: Estradiol and norethisterone acetate
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Nandrolone decanoate
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 119
Study: 31974691

Group type: EXPERIMENTAL
Intervention: Immediate total-body CT (iTBCT) scanning
Number of subjects: 1083

Group type: COMPARATOR
Intervention: Conventional imaging and selective CT
Number of subjects: 1083
Study: 31298405

Group type: EXPERIMENTAL
Intervention: 40:1 MI/DCI ratio, 2 g of inositols twice a day for 3 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Other ratios (1:3.5, 2.5:1, 5:1, 20:1, 80:1 MI/DCI)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: DCI alone
Number of subjects: 56
Study: 28091438

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg of 0.25% bupivacaine
Number of subjects: 56

Group type: COMPARATOR
Intervention: 0.5 ml/kg of 0.25% bupivacaine
Number of subjects: 56
Study: 27443567

Group type: EXPERIMENTAL
Intervention: Sevelamer (SV)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Cinacalcet (CC) with Sevelamer (SV)
Number of subjects: 466

Group type: EXPERIMENTAL
Intervention: Cinacalcet (CC) with Calcium Salts (CS)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Vitamin D (VD)
Number of subjects: 466
Study: 24981180

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA) and General Anesthesia (GA)
Number of subjects: 80
Study: 23075681

Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed (PC group)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin (GC group)
Number of subjects: 288
Study: 20578934

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309
Study: 17624996

Group type: COMPARATOR
Intervention: Single-blind placebo administration
Number of subjects: 321
Study: 16371156

Group type: EXPERIMENTAL
Intervention: Human metapneumovirus (hMPV) detection in AE-COPD patients
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (stable COPD)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (smokers without COPD)
Number of subjects: 130
Study: 12048340

Group type: EXPERIMENTAL
Intervention: Telephonic nursing case management
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard nursing care
Number of subjects: 111
Study: 10624256

Group type: EXPERIMENTAL
Intervention: Risk assessment and classification of pressure ulcers performed daily by nurses using the Modified Norton Scale (MNS) and a 'Pressure Ulcer Card'.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group where risk assessment and classification of pressure ulcers was not performed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical use of the Modified Norton Scale (MNS).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients who were confused on arrival.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of reported prevalence of pressure ulcers between experimental and control groups.
Number of subjects: 0
Study: 7611822

Group type: EXPERIMENTAL
Intervention: Topical IFN gamma-1 beta gel
Number of subjects: 33

Group type: COMPARATOR
Intervention: Laser surgery
Number of subjects: 33
Study: 2095801

Group type: EXPERIMENTAL
Intervention: Sorbitol gum chewed for 15 minutes after meal ingestion
Number of subjects: 5

Group type: COMPARATOR
Intervention: Fast-food meals without chewing gum
Number of subjects: 5
Study: 329980

Group type: EXPERIMENTAL
Intervention: adriamycin-cis-dichlorodiammineplatinum(II) (cis-platinum)
Number of subjects: 23

Group type: COMPARATOR
Intervention: adriamycin-cyclophosphamide
Number of subjects: 23
Study: 31441893

Group type: EXPERIMENTAL
Intervention: BoNTA injection (5 IU/cm)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 45
Study: 27683185

Group type: EXPERIMENTAL
Intervention: Calcium (2000 mg) and Vitamin D (1000 IU) supplementation
Number of subjects: 748
Study: 26123629

Group type: EXPERIMENTAL
Intervention: Gabapentin (100-600 mg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Clonazepam (0.5-2 mg/day)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Comparison of Gabapentin and Clonazepam
Number of subjects: 63
Study: 23175556

Group type: EXPERIMENTAL
Intervention: Oral artesunate 6 mg/kg/d (once-daily or twice-daily) for 7 days
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Oral artesunate 8 mg/kg/d (once-daily or twice-daily) for 3 days, followed by mefloquine
Number of subjects: 159

Group type: COMPARATOR
Intervention: All treatment arms (including both doses and schedules)
Number of subjects: 159
Study: 21397453

Group type: EXPERIMENTAL
Intervention: Mobile-bearing (MB) total knee arthroplasty
Number of subjects: 89

Group type: COMPARATOR
Intervention: Fixed-bearing total knee arthroplasty
Number of subjects: 89
Study: 19848563

Group type: EXPERIMENTAL
Intervention: Electronic decision-support tools embedded in the EMR
Number of subjects: 64150

Group type: COMPARATOR
Intervention: Control group (no electronic decision-support tools)
Number of subjects: 64150
Study: 17352022

Group type: EXPERIMENTAL
Intervention: VSL#3 (one sachet t.i.d.)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 490
Study: 15532847

Group type: EXPERIMENTAL
Intervention: Surgery plus preoperative treatment with recombinant human IL‐2 (9,000,000 IU for three consecutive days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Surgery alone (control group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Surgery plus preoperative treatment with recombinant human IL‐2
Number of subjects: 39
Study: 11804379

Group type: EXPERIMENTAL
Intervention: Chemotherapy for small-cell lung cancer (SCLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery or palliative chemotherapy for non-small-cell lung cancer (NSCLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life measurement tools (EORTC LC-13, FACT-L, LCSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-validated tools and poor methods of data analysis
Number of subjects: 0
Study: 9134073

Group type: EXPERIMENTAL
Intervention: Pergolide mesylate
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 7894627

Group type: EXPERIMENTAL
Intervention: 0.05% levocabastine eye drops and nasal spray plus topical placebos (twice daily)
Number of subjects: 110

Group type: COMPARATOR
Intervention: 2% sodium cromoglycate eye drops and nasal spray (four times daily)
Number of subjects: 110
Study: 3499074

Group type: EXPERIMENTAL
Intervention: Sucralfate suspension (1 g/10 ml every four hours)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Antacid titration (to maintain a gastric pH of more than 4)
Number of subjects: 74
Study: 31148204

Group type: EXPERIMENTAL
Intervention: TEG-guided transfusion strategy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard-of-care (SOC)
Number of subjects: 96
Study: 29609205

Group type: EXPERIMENTAL
Intervention: General practitioner screening for anxiety and depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (screening for pain intensity)
Number of subjects: 0
Study: 26406218

Group type: EXPERIMENTAL
Intervention: Laser (n = 15)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Taping applications (n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo Laser (n = 15)
Number of subjects: 45
Study: 26233647

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: New strict ECG criteria for CRT response
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: RV-LV-IED measurement
Number of subjects: 49
Study: 24119478

Group type: EXPERIMENTAL
Intervention: Noncemented total hip endoprosthesis after Chiari pelvic osteotomy
Number of subjects: 75

Group type: COMPARATOR
Intervention: Total hip arthroplasty due to degenerative hip dysplasia
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Comparison between groups
Number of subjects: 75
Study: 21076278

Group type: EXPERIMENTAL
Intervention: Etravirine (ETR) 400 mg daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Replacement of EFV with ETR
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Quality of sleep, depression, anxiety and stress scores
Number of subjects: 58
Study: 18362380

Group type: EXPERIMENTAL
Intervention: Fluoroquinolones (moxifloxacin, levofloxacin, gatifloxacin)
Number of subjects: 2133

Group type: EXPERIMENTAL
Intervention: Fluoroquinolones
Number of subjects: 2133
Study: 16290928

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP)
Number of subjects: 0
Study: 15204476

Group type: EXPERIMENTAL
Intervention: Health Education Programme
Number of subjects: 229

Group type: COMPARATOR
Intervention: Individual Intervention Programme
Number of subjects: 229
Study: 11257751

Group type: EXPERIMENTAL
Intervention: Local corticosteroid injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wrist splinting
Number of subjects: 30
Study: 9262126

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (150 mg daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 8517427

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3326874

Group type: EXPERIMENTAL
Intervention: Chalcone Ro 09-0410
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28726492

Group type: EXPERIMENTAL
Intervention: Non-specific computer training (NCT) using Nintendo Wii for improving functional performance
Number of subjects: 78

Group type: COMPARATOR
Intervention: Cognition-specific computer training (CCT) using CoTras for improving cognitive function
Number of subjects: 78
Study: 27208876

Group type: COMPARATOR
Intervention: Placebo control (soda water)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: SDF solution
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: SDF solution followed by potassium iodide (KI) solution
Number of subjects: 83
Study: 24735806

Group type: EXPERIMENTAL
Intervention: Bitopertin 10mg
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Bitopertin 30mg
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Olanzapine 15mg
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 22534589

Group type: EXPERIMENTAL
Intervention: Educational intervention (45-minute teaching session reviewing hospital bills and discussing cost reduction)
Number of subjects: 96
Study: 19735754

Group type: EXPERIMENTAL
Intervention: 5 microg/day vitamin D(3) supplementation
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: 10 microg/day vitamin D(3) supplementation
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (5 or 10 microg/day)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 18446736

Group type: EXPERIMENTAL
Intervention: Cool dialysate (35 degrees C)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Warm dialysate (37 degrees C)
Number of subjects: 7
Study: 15741544

Group type: EXPERIMENTAL
Intervention: Mirazid (300 mg/day for three consecutive days)
Number of subjects: 1131

Group type: COMPARATOR
Intervention: Praziquantel (single dose of 40 mg/kg)
Number of subjects: 1131
Study: 12875093

Group type: EXPERIMENTAL
Intervention: Home enteral nutrition (HEN) with a mean of 1650 Kcal of enteral solution
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Percutaneous gastrostomy
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Nasogastric tube
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Surgical gastrostomy
Number of subjects: 92
Study: 10215715

Group type: EXPERIMENTAL
Intervention: Laryngeal mask
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combitube
Number of subjects: 26
Study: 7762065

Group type: EXPERIMENTAL
Intervention: Enisoprost (EP) 100 mg p.o. t.i.d. for 12 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Enisoprost (EP)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 2685206

Group type: EXPERIMENTAL
Intervention: Training program (Quit for Life)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Patients of experimental physicians
Number of subjects: 44
Study: 30975478

Group type: EXPERIMENTAL
Intervention: Standard hip precautions (SHP)
Number of subjects: 313

Group type: COMPARATOR
Intervention: No hip precautions (NHP)
Number of subjects: 313
Study: 28110408

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with distraction osteogenesis (DO)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Extraction of lower premolars (Ex)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Nonex (without extractions)
Number of subjects: 55
Study: 26150704

Group type: EXPERIMENTAL
Intervention: Left radial approach (LRA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Right radial approach (RRA)
Number of subjects: 200
Study: 23523240

Group type: EXPERIMENTAL
Intervention: R-ZES
Number of subjects: 400

Group type: COMPARATOR
Intervention: PES
Number of subjects: 400
Study: 21880792

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 1717
Study: 19640733

Group type: COMPARATOR
Intervention: Recovery filter
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: G2 filter
Number of subjects: 241
Study: 17596694

Group type: EXPERIMENTAL
Intervention: Iscador therapy (mistletoe preparation)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no Iscador therapy)
Number of subjects: 187
Study: 15345106

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 18) informed of the protective effect of beta-thalassemia trait against malaria and coronary heart disease
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (n = 10) received the same information after the second interview
Number of subjects: 28
Study: 11159657

Group type: EXPERIMENTAL
Intervention: Immediate antibiotics
Number of subjects: 315

Group type: COMPARATOR
Intervention: Delayed antibiotics
Number of subjects: 315
Study: 10093796

Group type: EXPERIMENTAL
Intervention: Intraarticular injections of sodium hyaluronate (20 mg) plus steroid (20 mg triamcinolone acetonide) and physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intraarticular injections of steroid (20 mg triamcinolone acetonide) alone and physiotherapy
Number of subjects: 30
Study: 7820469

Group type: EXPERIMENTAL
Intervention: Stripping of the long saphenous vein (LSV)
Number of subjects: 89
Study: 2945705

Group type: EXPERIMENTAL
Intervention: 1% metronidazole in an emollient cream base
Number of subjects: 75

Group type: COMPARATOR
Intervention: 250 mg oral tetracycline taken twice daily
Number of subjects: 75
Study: 30052315

Group type: EXPERIMENTAL
Intervention: CRMRF (calorie-restricted diet with meal replacement and fish oil supplementation)
Number of subjects: 93

Group type: COMPARATOR
Intervention: CRMR (calorie-restricted diet with meal replacement alone)
Number of subjects: 93
Study: 27016729

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotics (haloperidol and flupentixol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second-generation antipsychotics (olanzapine, aripiprazole and quetiapine)
Number of subjects: 0
Study: 24393305

Group type: EXPERIMENTAL
Intervention: Telephone outcall intervention program
Number of subjects: 230

Group type: COMPARATOR
Intervention: Minimal outcall / attention control service
Number of subjects: 230
Study: 22307237

Group type: EXPERIMENTAL
Intervention: Periconceptional maternal micronutrient supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 20473735

Group type: EXPERIMENTAL
Intervention: Valsartan (80 mg once a day)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Xuezhikang Capsule (600 mg, twice a day) and Valsartan (80 mg once a day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Xuezhikang Capsule and Valsartan vs Control group
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Xuezhikang Capsule and Valsartan vs Valsartan group
Number of subjects: 90
Study: 18678684

Group type: EXPERIMENTAL
Intervention: Telephone-delivered interpersonal psychotherapy (teletherapy group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 79
Study: 18539223

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Conventional PCI
Number of subjects: 1071
Study: 15470940

Group type: EXPERIMENTAL
Intervention: School-based drug abuse prevention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no drug prevention program)
Number of subjects: 0
Study: 11226996

Group type: EXPERIMENTAL
Intervention: Granisetron (40 microg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Droperidol (50 microg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Metoclopramide (0.25 mg/kg)
Number of subjects: 90
Study: 9028087

Group type: EXPERIMENTAL
Intervention: Aprotinin 2 million KIU
Number of subjects: 21

Group type: COMPARATOR
Intervention: Normal saline placebo (control)
Number of subjects: 21
Study: 8471083

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 g/kg)
Number of subjects: 10
Study: 2980546

Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 20

Group type: COMPARATOR
Intervention: meglumine-Ca-metrizoate
Number of subjects: 20
Study: 31254675

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 199
Study: 30159739

Group type: EXPERIMENTAL
Intervention: Knee brace (12 weeks postoperative therapy)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Wedge insoles (12 weeks postoperative therapy)
Number of subjects: 63

Group type: COMPARATOR
Intervention: No specific postoperative therapy (control group)
Number of subjects: 63
Study: 29049469

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone, 380 mg, administered intramuscularly every fourth week for 12 weeks
Number of subjects: 232

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone, daily oral flexible dose 4 to 24 mg/d
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 232

Group type: COMPARATOR
Intervention: Buprenorphine-naloxone
Number of subjects: 232